
Bioceres Crop Solutions Corp.
BIOXNASDAQBasic MaterialsAgricultural Inputs
Regular session
$0.4279
−$0.013 · -2.95%
BIOX company overview
Regular session · ET · Market data may be delayed.
GoAI snapshot
AI-powered factor overview
GoAI score
Sell
Trim exposure — unfavorable risk-reward
Valuation
47
Fair Value
Momentum
19
Strong Down
Sentiment
40
Bearish
Risk resilience
34
High Risk
Full GoAI research
Thesis, catalysts, evidence, and risk analysis.
AI-generated, informational only, and not investment advice.
Company profile
Company websiteBioceres Crop Solutions Corp. (BIOX) is a company dedicated to enhancing agricultural output through a diverse range of solutions. Its operations are organized into three principal divisions. The Seed and Integrated Products segment is responsible for creating and bringing to market cutting-edge seed technologies, genetic material, biotechnological innovations, and specialized seed coatings. Under its Crop Protection segment, the company formulates, manufactures, and distributes a comprehensive array of products, including Rizoderma, various adjuvants, therapeutic agents, weed killers, insect eradicators, fungal treatments, and pest lures. The Crop Nutrition unit focuses on the development, production, and distribution of inoculants, bio-stimulants, and both organic and micro-granular fertilizers. A notable offering from Bioceres is HB4, an innovative seed technology engineered for drought resistance. The enterprise maintains a significant presence across several countries, including Argentina, Uruguay, France, and South Africa, alongside broader international operations. Established in 2001, the firm's main offices are situated in Rosario, Argentina. Bioceres Crop Solutions Corp. functions as a subsidiary entity under the umbrella of Bioceres LLC.
- Industry
- Agricultural Inputs
- Sector
- Basic Materials
- Headquarters
- AR
- CEO
- Federico Trucco
- Listed since
- Mar 22, 2018
- Employees
- 751
Market position
Day range
Current $0.4279
52-week range
Current $0.4279
- Open
- $0.44
- Previous close
- $0.4409
- Volume
- 22.97K
- 0.09× average
- Average volume
- 247.43K
- Average daily volume
- Market cap
- 27.06M USD
- Beta
- 0.4
- Market reference 1
- 50-day average
- $0.3669
- +16.63% above average
- 200-day average
- $0.7566
- -43.45% below average
Financials
Financial snapshot
Latest / TTMValuation & yield
- P/E (TTM)
- -0.11×
- P/B (TTM)
- 0.43×
- P/S (TTM)
- 0.1×
- Dividend yield
- 0.00%
Profitability & efficiency
- Gross margin
- 36.71%
- Operating margin
- 0.82%
- Net margin
- -95.02%
Financial health
- Debt / equity
- 3.76×
Financial statements
Margin trends
Profitability as a percentage of reported revenue.
Income trends
Revenue
Operating income
Net income
| Metric (USD) | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 |
|---|---|---|---|---|---|
| Revenue | 333.34M USD | 464.83M USD | 419.45M USD | 328.46M USD | 206.7M USD |
| Cost of goods sold | 205.19M USD | 283.24M USD | 239.2M USD | 202.02M USD | 115.82M USD |
| Gross profit | 128.15M USD | 181.59M USD | 180.25M USD | 126.44M USD | 90.88M USD |
| Research and development | 14.91M USD | 17.18M USD | 15.35M USD | 6.95M USD | 5.62M USD |
| Selling, general, and administrative | 88.35M USD | 94.27M USD | 85.54M USD | 57.36M USD | 44.39M USD |
| Operating expenses | 128.91M USD | 136.77M USD | 111.76M USD | 84.91M USD | 49.97M USD |
| Interest expense | 25.63M USD | 26.87M USD | 23.79M USD | 17.93M USD | 21.24M USD |
| Depreciation and amortization | 22.18M USD | 21.3M USD | 19.39M USD | 9.19M USD | 6.26M USD |
| Operating income | −761.9K USD | 44.82M USD | 54.18M USD | 39.87M USD | 38.38M USD |
| Net income | −55.42M USD | 3.24M USD | 18.78M USD | −7.2M USD | −6.87M USD |
Company facts updated Aug 24, 2026.
Analyst ratings
Third-party consensus; not a GoAI recommendation.
Analyst price target
Average target
$8.00
1769.60% upsideRating distribution
5 ratingsBIOX news
BIOX peers
ETFs holding BIOX
Funds reporting this stock among their holdings, ordered by reported position size.
Continue in GoAI
Research BIOXresearch.disclaimer







